Alkermes plc. Officer Sells 4,000 Shares

TradingView
2025.12.01 22:50
portai
I'm PortAI, I can summarize articles.

Reporter NameHopkinson Craig C.RelationshipEVP R&D, Chief Medical OfficerTypeSellAmount$117,200SEC FilingForm 4Craig C. Hopkinson, EVP R&D and Chief Medical Officer of Alkermes plc., sold 4,000 ordinary shares on December 1, 2025, at a price of $29.3 per share, totaling $117,200. Following the transaction, Hopkinson directly owns 65,740 ordinary shares of the company. The sale was conducted under a Rule 10b5-1 trading plan adopted on March 14, 2025.SEC Filing: Alkermes plc. [ ALKS ] - Form 4 - Dec. 01, 2025

Reporter NameHopkinson Craig C.
RelationshipEVP R&D, Chief Medical Officer
TypeSell
Amount$117,200
SEC FilingForm 4

Craig C. Hopkinson, EVP R&D and Chief Medical Officer of Alkermes plc., sold 4,000 ordinary shares on December 1, 2025, at a price of $29.3 per share, totaling $117,200. Following the transaction, Hopkinson directly owns 65,740 ordinary shares of the company. The sale was conducted under a Rule 10b5-1 trading plan adopted on March 14, 2025.

SEC Filing: Alkermes plc. [ ALKS ] - Form 4 - Dec. 01, 2025

Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer